Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Comment by garygpon May 29, 2022 4:32pm
111 Views
Post# 34715721

RE:RE:RE:Expecting tangible news soon

RE:RE:RE:Expecting tangible news soonM101, I agree with both you and goldtech and see both arguments.

I’m wondering if management will do the consolidation sooner than later to get it out of the the way, get to the Nasdaq sooner, and have Promis established there so that when news flows in early 2023 we hit the ground running.

I shudder everytime I think of the consolidation knowing Williams and Goldstein have sold us down the river for their own greasy, greedy self preservation and enrichment.  It’s too late to rehash the past so let’s endure the pain and get on with it.

I do hope that  neither of the aforementioned ever have the opportunity to do to other shareholders  in other companies what they done to ProMIS,  and their rein of stupidity and lack of honesty and integrity  ends here.
<< Previous
Bullboard Posts
Next >>